Ruth Ganss
Ruth Ganss
Head Vascular Biology and Stromal Targeting, Harry Perkins Institute of Medical Research
Verified email at uwa.edu.au
Title
Cited by
Cited by
Year
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
R Du, KV Lu, C Petritsch, P Liu, R Ganss, E Passegué, H Song, ...
Cancer cell 13 (3), 206-220, 2008
11572008
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
J Hamzah, M Jugold, F Kiessling, P Rigby, M Manzur, HH Marti, T Rabie, ...
Nature 453 (7193), 410-414, 2008
4812008
Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors
E Hummler, TJ Cole, JA Blendy, R Ganss, A Aguzzi, W Schmid, ...
Proceedings of the National Academy of Sciences 91 (12), 5647-5651, 1994
4261994
Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication
R Ganss, E Ryschich, E Klar, B Arnold, GJ Hämmerling
Cancer research 62 (5), 1462-1470, 2002
3282002
Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in …
K Schledzewski, M Falkowski, G Moldenhauer, P Metharom, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
2772006
Chemokines direct endothelial progenitors into tumor neovessels
H Spring, T Schüler, B Arnold, GJ Hämmerling, R Ganss
Proceedings of the National Academy of Sciences 102 (50), 18111-18116, 2005
2702005
NK-and CD8+ T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides
Y Kawarada, R Ganss, N Garbi, T Sacher, B Arnold, GJ Hämmerling
The Journal of Immunology 167 (9), 5247-5253, 2001
2322001
Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
M Berger, G Bergers, B Arnold, GJ Hämmerling, R Ganss
Blood 105 (3), 1094-1101, 2005
1912005
Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes
R Ganss, D Hanahan
Cancer research 58 (20), 4673-4681, 1998
1571998
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction
N Garbi, B Arnold, S Gordon, GJ Hämmerling, R Ganss
The Journal of Immunology 172 (10), 5861-5869, 2004
1482004
A cell‐specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number‐related expression in transgenic mice.
R Ganss, L Montoliu, AP Monaghan, G Schütz
The EMBO Journal 13 (13), 3083-3093, 1994
1331994
Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy
A Johansson, J Hamzah, CJ Payne, R Ganss
Proceedings of the National Academy of Sciences 109 (20), 7841-7846, 2012
1242012
Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM
R Du, C Petritsch, K Lu, P Liu, A Haller, R Ganss, H Song, S Vandenberg, ...
Neuro-oncology 10 (3), 254-264, 2008
1092008
Transformation of the microvascular system during multistage tumorigenesis
E Ryschich, J Schmidt, GJ Hämmerling, E Klar, R Ganss
International journal of cancer 97 (6), 719-725, 2002
1092002
The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements.
R Ganss, G Schütz, F Beermann
Journal of Biological Chemistry 269 (47), 29808-29816, 1994
1051994
Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma
E Ryschich, P Lizdenis, C Ittrich, A Benner, S Stahl, A Hamann, J Schmidt, ...
Cancer research 66 (1), 198-211, 2006
872006
Secreted frizzled-related protein 4: an angiogenesis inhibitor
A Muley, S Majumder, GK Kolluru, S Parkinson, H Viola, L Hool, F Arfuso, ...
The American journal of pathology 176 (3), 1505-1516, 2010
802010
Mini‐review: overcoming tumor‐intrinsic resistance to immune effector function
R Ganss, B Arnold, GJ Hämmerling
European journal of immunology 34 (10), 2635-2641, 2004
782004
De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors
A Johansson-Percival, B He, ZJ Li, A Kjellén, K Russell, J Li, I Larma, ...
Nature immunology 18 (11), 1207, 2017
702017
The cyclic adenosine 3', 5'-monophosphate-and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription.
R Ganss, F Weih, G Schütz
Molecular Endocrinology 8 (7), 895-903, 1994
681994
The system can't perform the operation now. Try again later.
Articles 1–20